Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free AGIO Stock Alerts

Agios Pharmaceuticals (AGIO) Short Interest Ratio & Short Volume

Agios Pharmaceuticals logo
$29.46 0.00 (0.00%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$28.80 -0.66 (-2.24%)
As of 06/12/2026 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Agios Pharmaceuticals Short Interest Overview

As of May 29, 2026, Agios Pharmaceuticals (AGIO) had a short interest of 6.93 million shares sold short, representing 12.31% of the public float. This marks a -7.03% decrease in short interest since the prior report. The short interest ratio (days to cover) is 8.2, meaning it would take 8.2 days of the average trading volume of 887,231 shares to cover all short positions.

Current Short Interest
6,926,807 shares
Previous Short Interest
7,450,870 shares
Change Vs. Previous Month
-7.03%
Dollar Volume Sold Short
$203.65 million
Short Interest Ratio
8.2 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
59,470,000 shares
Short Percent of Float
12.31%
Today's Trading Volume
1,141,117 shares
Average Trading Volume
887,231 shares
Today's Volume Vs. Average
129%
Short Selling Agios Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Agios Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AGIO Short Interest Over Time

AGIO Days to Cover Over Time

AGIO Percentage of Float Shorted Over Time

Agios Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/20266,926,807 shares $203.65 million -7.0%12.3%8.16 $29.40
5/15/20267,450,870 shares $209.89 million +6.8%13.2%8.67 $28.17
4/30/20266,974,194 shares $195.28 million -1.5%12.4%4.18 $28.00
4/15/20267,082,292 shares $243.98 million +7.2%12.6%6.95 $34.45
3/31/20266,606,016 shares $223.48 million +6.7%11.8%6.36 $33.83
3/13/20266,189,757 shares $172.38 million -0.8%11.1%8.19 $27.85
2/27/20266,239,478 shares $188.62 million -1.4%11.2%8.57 $30.23
2/13/20266,326,274 shares $176.88 million -6.0%11.4%7.12 $27.96
1/30/20266,728,796 shares $184.64 million -9.7%12.1%7.27 $27.44
1/15/20267,449,166 shares $207.09 million +5.1%13.4%7.83 $27.80
12/31/20257,089,960 shares $192.99 million +15.7%12.8%3.63 $27.22
12/15/20256,126,003 shares $164.48 million +12.1%11.0%4.82 $26.85
11/28/20255,466,677 shares $159.93 million +26.2%9.9%1.3 $29.26
11/14/20254,331,538 shares $189.07 million -5.9%7.8%7.09 $43.65
10/31/20254,601,630 shares $198.97 million -7.5%8.3%7.75 $43.24
10/15/20254,970,000 shares $205.66 million -4.1%9.1%6.6 $41.38
9/30/20255,180,000 shares $207.93 million +9.3%9.4%6.5 $40.14
9/15/20254,740,000 shares $172.06 million -0.4%8.6%6 $36.30
8/31/20254,760,000 shares $179.50 million -1.2%8.8%6 $37.71
8/15/20254,820,000 shares $178.39 million +17.6%8.9%6.5 $37.01
7/31/20254,100,000 shares $152.60 million -1.9%7.4%5.5 $37.22
7/15/20254,180,000 shares $163.81 million +10.6%7.6%7 $39.19
6/30/20253,780,000 shares $125.72 million -12.5%6.8%6.3 $33.26
6/15/20254,320,000 shares $148.18 million +1.7%7.8%7.2 $34.30
5/31/20254,250,000 shares $137.66 million +2.2%7.7%6.8 $32.39
5/15/20254,160,000 shares $117.56 million +5.9%7.5%6.5 $28.26
4/30/20253,930,000 shares $116.68 million +12.9%7.1%5.9 $29.69
4/15/20253,480,000 shares $96.81 million -2.0%6.3%5.2 $27.82
3/31/20253,550,000 shares $104.02 million +4.4%6.4%4.8 $29.30
3/15/20253,400,000 shares $105.16 million -13.7%6.2%4.3 $30.93
2/28/20253,940,000 shares $140.03 million -14.9%7.1%4.4 $35.54
2/15/20254,630,000 shares $153.81 million -8.0%8.4%5.4 $33.22
1/31/20255,030,000 shares $172.98 million -6.0%9.1%5.7 $34.39
1/15/20255,350,000 shares $178.05 million -3.3%9.7%6.2 $33.28
12/31/20245,530,000 shares $181.72 million +8.0%10.0%6.6 $32.86
12/15/20245,120,000 shares $199.50 million +12.0%9.3%6.4 $38.97
11/30/20244,570,000 shares $271.41 million +0.4%8.3%6.9 $59.39
11/15/20244,550,000 shares $244.70 million +4.8%8.3%8 $53.78
10/31/20244,340,000 shares $192.83 million +5.6%7.9%8.3 $44.43
10/15/20244,110,000 shares $172.78 million +25.3%7.5%8.8 $42.04
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
9/30/20243,280,000 shares $145.73 million +10.1%6.0%6.5 $44.43
9/15/20242,980,000 shares $139.14 million +2.8%5.4%6.5 $46.69
8/31/20242,900,000 shares $133.14 million -16.2%5.3%5.4 $45.91
8/15/20243,460,000 shares $155.39 million -2.5%6.3%4.9 $44.91
7/31/20243,550,000 shares $164.72 million +11.3%6.4%4.7 $46.40
7/15/20243,190,000 shares $149.80 million +1.9%5.8%4 $46.96
6/30/20243,130,000 shares $134.97 million -25.8%5.7%3.9 $43.12
6/15/20244,220,000 shares $186.14 million -5.6%7.6%5.3 $44.11
5/31/20244,470,000 shares $162.44 million -26.5%8.1%6 $36.34
5/15/20246,080,000 shares $213.89 million -6.6%11.0%8.5 $35.18
4/30/20246,510,000 shares $211.58 million -2.1%11.8%8.5 $32.50
4/15/20246,650,000 shares $194.58 million +0.8%12.2%8.9 $29.26
3/31/20246,600,000 shares $192.98 million -3.7%12.1%8.3 $29.24
3/15/20246,850,000 shares $205.09 million -6.6%12.5%8.3 $29.94
2/29/20247,330,000 shares $236.91 million -4.2%13.4%8.8 $32.32
2/15/20247,650,000 shares $205.02 million +4.2%14.0%10 $26.80
1/31/20247,340,000 shares $166.03 million -8.6%13.4%11.3 $22.62
1/15/20248,030,000 shares $182.60 million +13.1%14.7%11.5 $22.74
12/31/20237,100,000 shares $158.12 million +3.4%13.0%10.9 $22.27
12/15/20236,870,000 shares $159.66 million +7.2%12.5%11.6 $23.24
11/30/20236,410,000 shares $142.49 million +6.5%11.7%11.7 $22.23
11/15/20236,020,000 shares $135.27 million +6.4%11.0%11.3 $22.47
10/31/20235,660,000 shares $118.92 million +2.5%10.6%11.2 $21.01
10/15/20235,520,000 shares $127.62 million -5.5%10.3%13.3 $23.12
9/30/20235,840,000 shares $144.54 million -3.5%10.9%15.3 $24.75
9/15/20236,050,000 shares $157.84 million +2.5%11.3%16.6 $26.09
8/31/20235,900,000 shares $161.84 million -1.0%11.0%15.2 $27.43
8/15/20235,960,000 shares $165.39 million -1.5%11.2%14.4 $27.75
7/31/20236,050,000 shares $160.45 million -2.9%11.3%14.1 $26.52
7/15/20236,230,000 shares $169.58 million +5.4%11.7%13.4 $27.22
6/30/20235,910,000 shares $167.37 million +2.4%11.1%12.7 $28.32
6/15/20235,770,000 shares $148.92 million +0.5%10.8%12.2 $25.81
5/31/20235,740,000 shares $145.11 million -0.9%10.8%12.1 $25.28
5/15/20235,790,000 shares $151.70 million +1.6%10.9%11.3 $26.20
4/30/20235,700,000 shares $130.36 million +6.3%10.7%10.8 $22.87
4/15/20235,360,000 shares $117.60 million -6.9%10.1%10 $21.94
3/31/20235,760,000 shares $132.31 million -3.2%10.9%10.8 $22.97
3/15/20235,950,000 shares $140.60 million +1.2%11.2%11.4 $23.63
2/28/20235,880,000 shares $148.82 million +1.7%11.1%11.4 $25.31
2/15/20235,780,000 shares $160.16 million +0.2%11.0%11.9 $27.71
1/31/20235,770,000 shares $170.10 million -13.8%10.9%12.1 $29.48
1/15/20236,690,000 shares $199.16 million -1.2%12.7%13.5 $29.77
12/30/20226,770,000 shares $190.10 million +2.1%12.8%14.3 $28.08
12/15/20226,630,000 shares $196.98 million +4.1%12.6%13 $29.71
11/30/20226,370,000 shares $191.99 million +1.0%12.1%11.2 $30.14
11/15/20226,310,000 shares $179.27 million -1.1%12.0%9.4 $28.41
10/31/20226,380,000 shares $175.71 million +7.4%12.1%9.2 $27.54
10/15/20225,940,000 shares $160.20 million +6.6%11.3%8.1 $26.97
9/30/20225,570,000 shares $157.52 million -1.9%10.6%7.6 $28.28
9/15/20225,680,000 shares $193.57 million +3.3%10.5%7.5 $34.08
Goldman Sachs just told you what to buy (most people missed it) (Ad)

Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel

See the stock positioned to solve AI's biggest power crisis
8/31/20225,500,000 shares $140.25 million -11.0%10.2%6.9 $25.50
8/15/20226,180,000 shares $174.96 million -4.2%11.4%8.8 $28.31
7/31/20226,450,000 shares $139.13 million +3.4%12.7%8.8 $21.57
7/15/20226,240,000 shares $139.21 million +1.5%12.3%8.7 $22.31
6/30/20226,150,000 shares $136.35 million -4.2%12.1%8.4 $22.17
6/15/20226,420,000 shares $117.68 million -1.7%12.6%9.4 $18.33
5/31/20226,530,000 shares $127.14 million +9.0%12.1%11 $19.47
5/15/20225,990,000 shares $132.50 million +1.5%11.1%10 $22.12
4/30/20225,900,000 shares $129.62 million -6.9%10.9%10.1 $21.97
4/15/20226,340,000 shares $176.89 million +3.3%11.8%11.1 $27.90
3/31/20226,140,000 shares $178.74 million -2.9%11.4%11.2 $29.11
3/15/20226,320,000 shares $171.78 million +2.3%11.7%11.2 $27.18
2/28/20226,180,000 shares $192.38 million -0.3%11.5%9.7 $31.13
2/15/20226,200,000 shares $193.63 million +2.3%11.6%9.4 $31.23
1/31/20226,060,000 shares $187.19 million +4.3%11.3%9.9 $30.89
1/15/20225,810,000 shares $192.54 million +4.3%10.8%10 $33.14
12/31/20215,570,000 shares $183.09 million -14.6%10.4%10 $32.87
12/15/20216,520,000 shares $213.60 million -12.0%12.2%11.8 $32.76
11/30/20217,410,000 shares $263.94 million -2.1%13.8%16.1 $35.62
11/15/20217,570,000 shares $307.19 million +7.5%14.1%18.6 $40.58
10/29/20217,040,000 shares $330.88 million +5.6%13.2%16.4 $47.00
10/15/20216,670,000 shares $308.69 million +7.4%11.5%13.4 $46.28
9/30/20216,210,000 shares $286.59 million +8.6%10.7%10.9 $46.15
9/15/20215,720,000 shares $263.75 million +1.4%9.8%7.9 $46.11
8/31/20215,640,000 shares $252.00 million +1.3%9.7%7.5 $44.68
8/13/20215,570,000 shares $244.80 million +15.8%9.5%7.4 $43.95
7/30/20214,810,000 shares $231.31 million -4.4%8.2%6.3 $48.09
7/15/20215,030,000 shares $282.18 million +10.3%8.3%7 $56.10
6/30/20214,560,000 shares $251.30 million +2.5%7.5%6.5 $55.11
6/15/20214,450,000 shares $258.90 million -4.7%7.3%7.2 $58.18

AGIO Short Interest - Frequently Asked Questions

Short interest is the volume of Agios Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 6,926,807 shares of AGIO short. 12.31% of Agios Pharmaceuticals' shares are currently sold short. Learn More on Agios Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGIO shares currently have a short interest ratio of 8.2. Learn More on Agios Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.31% of Agios Pharmaceuticals' floating shares are currently sold short.

Agios Pharmaceuticals saw a drop in short interest during the month of May. As of May 29th, there was short interest totaling 6,926,807 shares, a drop of 7.0% from the previous total of 7,450,870 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.31% of Agios Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Agios Pharmaceuticals: Lantheus Holdings, Inc. (8.56%), Spyre Therapeutics, Inc. (17.25%), Immunovant, Inc. (9.53%), Protagonist Therapeutics, Inc. (12.15%), TG Therapeutics, Inc. (20.60%), Kymera Therapeutics, Inc. (14.62%), Legend Biotech Corporation Sponsored ADR (6.77%), Rhythm Pharmaceuticals, Inc. (12.27%), Centessa Pharmaceuticals PLC Sponsored ADR (1.80%), PTC Therapeutics, Inc. (13.62%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling AGIO is an investing strategy that aims to generate trading profit from Agios Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Agios Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGIO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGIO, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AGIO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AGIO) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel